Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Interest & Investment Income: 2019-2023

Historic Interest & Investment Income for ADC Therapeutics (ADCT) over the last 5 years, with Sep 2023 value amounting to $2.7 million.

  • ADC Therapeutics' Interest & Investment Income rose 890.11% to $2.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $7.4 million, marking a year-over-year decrease of 60.31%. This contributed to the annual value of $17,970 for FY2022, which is 27127.27% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Interest & Investment Income is $2.7 million, which was up 13.95% from $2.4 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Interest & Investment Income registered a high of $18.3 million during Q1 2022, and its lowest value of $20 during Q4 2021.
  • For the 3-year period, ADC Therapeutics' Interest & Investment Income averaged around $2.4 million, with its median value being $16,000 (2022).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first slumped by 95.99% in 2021, then skyrocketed by 121,953.33% in 2022.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Interest & Investment Income stood at $218 in 2019, then surged by 22,259.40% to $163,000 in 2020, then tumbled by 90.18% to $20 in 2021, then soared by 8,035.00% to $1,627 in 2022, then soared by 890.11% to $2.7 million in 2023.
  • Its last three reported values are $2.7 million in Q3 2023, $2.4 million for Q2 2023, and $2.3 million during Q1 2023.